Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GOVX @ .07. Right @ 200DMA. Decent volume.
ROKA: Moving up through resistance. Cash rich. Microfloat
Congrats to those loading before Fed $$ Zika news
Right back to 200DMA. Buyers watching for entry
GOVX: Picked up some on the dip.
Always good to have a bid in.
Very nice.
NTRPD: Move up & through uplist may be big.
In for the science & the momo.
GOVX: Steady hits on 200DMA on low volume. Going to pop.
GOVX in nice uptrend now.
Growing investor base & huge additions to scientific team.
Looking very nice, indeed.
GOVX: Important .07 level seems ripe for takeout.
Very light Friday volume, but still could go higher as investors set up for Monday.
News pending on multiple fronts.
A move into .08s today would be a huge buy signal
ROKA @ $4.40s...$17.86 cash a share. Micro-floater.
They will be teeing this one up at some point.
Link:
http://finviz.com/quote.ashx?t=roka
ROKA @ $4.40s...$17.86 cash a share. Micro-floater.
They will be teeing this one up at some point.
Link:
http://finviz.com/quote.ashx?t=roka
GOVX: Second source?: Geovax, Zika & 60 Minutes.
Looking over a 1/18/17 article in FierceBiotech there is a reference to the Zika Vaccine & Geovax.
It would be interesting if someone spoke with the author in regard to the Zika reference in the article.
"Chasing that goal, GeoVax and Georgia State say they are working on developing several vaccine candidates. The biotech—also based in Georgia—will contribute its modified vaccinie Ankara virus technology platform, which can be used to stimulate virus-like particles (VLPs) against specific antigens in patients and is already being used in vaccines against Zika and other serious diseases."
FierceBiotech article Link:
http://www.fiercebiotech.com/biotech/geovax-draws-a-bead-hep-b-therapeutic-vaccine-deal
NOTE: The hundreds of millions of dollars allocated by Congress for Zika in late 2016 is yet to be distributed. GeoVax applied for funding in April 2016 and that news is due. GeoVax is almost certainly in line for a Fed grant. Substantial cash in regard to the company market cap perhaps.
GeoVax Zika funding request link: April, 2016:
https://www.geovax.com/news-events/entry/2016/04/18/geovax-provides-update-on-zika-vaccine-program.html
GOVX: Big bids right below .07 Who breaks it out?
Looking quite good ahead of the .07 breakout.
Likely to move quite nicely higher just on the technicals.
Great spot.
GOVX @ .06. $3.2M market cap. Injecting human AIDS vax started.
Based on sheer bang for the buck, there is no stock that matches GeoVax right now.
Just astounding that GOVX is trading @ .07 cents with a $3.3M $$ market cap.
The biggest names in vaccine science have gravitated to GeoVax in the last few weeks in an advisory capacity, chaired by Dr. Thomas Monath.
Dr. Monath is the developer of the 100% effective Ebola vaccine for Merck via NewLink that made such sensational news recently.
In addition, the Chief Science Officer for GeoVax is Dr.Farshad Guirakhoo, the former Senior VP of Sanofi. He was recently ranked #22 on the "List of 50 Most Important People in Vaccines"..........ahead of Dr. Anthony Fauuci, the Director of NIAD.
GeoVax made news this week by announcing that their latest round of human vaccinations to prevent AIDS is now underway. They are one of an elite handful of companies around the world participating at that level. The entire GeoVax AIDS vaccination program is being funded by NIAD.
Hard to believe that GeoVax is also well along on programs for Zika, Ebola, Dengue Fever and more than a few others.
Do your DD on GOVX and put it up on your screen.
This one is going to go big, imo.
AIDS vax news:
https://www.geovax.com/news-events/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html
Newly formed Science Advisory Board:
https://www.geovax.com/about-geovax.html
GOVX: #1 bio/pharma to own now trading on any market.
Based on sheer bang for the buck, there is no stock that matches GeoVax right now.
Just astounding that the GOVX is trading @ .07 cents with a $3.3M $$ market cap.
The biggest names in vaccine science have gravitated to GeoVax in the last few weeks in an advisory capacity, chaired by Dr. Thomas Monath.
Dr. Monath is the developer of the 100% effective Ebola vaccine for Merck via NewLink that made such sensational news recently.
In addition, the Chief Science Officer for GeoVax is Dr.Farshad Guirakhoo, the former Senior VP of Sanofi. He was recently ranked #22 on the "List of 50 Most Important People in Vaccines"..........ahead of Dr. Anthony Fauuci, the Director of NIAD.
GeoVax made news this week by announcing that their latest round of human vaccinations to prevent AIDS is now underway. They are one of an elite handful of companies around the world participating at that level. The entire GeoVax AIDS vaccination program is being funded by NIAD.
Hard to believe that GeoVax is also well along on programs for Zika, Ebola, Dengue Fever and more than a few others.
Do your DD on GOVX and put it up on your screen.
This one is going to go big, imo.
AIDS vax news:
https://www.geovax.com/news-events/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html
Newly formed Science Advisory Board:
https://www.geovax.com/about-geovax.html
GOVX: #1 bio/pharma to own now trading on any market.
Based on sheer bang for the buck, there is no stock that matches GeoVax right now.
Just astounding that the GOVX is trading @ .07 cents with a $3.3M $$ market cap.
The biggest names in vaccine science have gravitated to GeoVax in the last few weeks in an advisory capacity, chaired by Dr. Thomas Monath.
Dr. Monath is the developer of the 100% effective Ebola vaccine for Merck via NewLink that made such sensational news recently.
In addition, the Chief Science Officer for GeoVax is Dr.Farshad Guirakhoo, the former Senior VP of Sanofi. He was recently ranked #22 on the "List of 50 Most Important People in Vaccines"..........ahead of Dr. Anthony Fauuci, the Director of NIAD.
GeoVax made news this week by announcing that their latest round of human vaccinations to prevent AIDS is now underway. They are one of an elite handful of companies around the world participating at that level. The entire GeoVax AIDS vaccination program is being funded by NIAD.
Hard to believe that GeoVax is also well along on programs for Zika, Ebola, Dengue Fever and more than a few others.
Do your DD on GOVX and put it up on your screen.
This one is going to go big, imo.
AIDS vax news:
https://www.geovax.com/news-events/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html
Newly formed Science Advisory Board:
https://www.geovax.com/about-geovax.html
GOVX: GeoVax Twitter site.
Link:
https://twitter.com/Geovax_News
GOVX: Getting volume @200DMA
Nice volume. Near breakout
OVAS @ $1.64 in pre. Has approx $3.75 cash a share.
Low volume in pre but its up.
Lets see if it can generate 2+ Mil shares today and move higher.
GOVX @ .06: Human AIDS vaccination program begins. $3.2M market cap
This is the highly anticipated next step in the GeoVax AIDS prevention vaccine program.
GeoVax is a multibagger and then some.
Link:
http://finance.yahoo.com/news/geovax-announces-initiation-hiv-human-140000997.html
GeoVax website:
https://www.geovax.com/
GOVX @ .06: Human AIDS vaccination program begins. $3.2M market cap
This is the highly anticipated next step in the GeoVax AIDS prevention vaccine program.
GeoVax is a multibagger and then some.
Link:
http://finance.yahoo.com/news/geovax-announces-initiation-hiv-human-140000997.html
GeoVax website:
https://www.geovax.com/
OVAS @ $1.62 on strong volume.
May go.
CPIX: FDA approval on 1/23/17?.No news release yet?
Need some DD on this.
Looks like they got FDA approval for a new formulation or indication for Acetadote,. The drug is an injectable used to halt liver damage.
CPIX is very thinly traded and has a nice business going with good cash.
NOTE: DO NOT buy the stock on this DD.....although I think it is correct. Do your own DD. DO NOT rely on this post. I am asking if its approved not claiming it is approved.
LINK:
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=report.page
OVAS @ $1.60: Under cash crowd on it. Good play.
XON buys out GNVC drug platform. GOVX next?
Link:
http://finance.yahoo.com/news/intrexon-acquire-genvec-expand-industry-140000103.html
Re-Post of DD on 60 Minutes from 11/16 on Zika Virus.
NOTE: This post came and went, receiving little attention. GeoVax is never mentioned in the piece. Had the name been mentioned the stock would have moved way higher. Instead, the stock dropped...:).
NOTE 2: I believe the same platform that is used in the Zika Virus vaccine is also used in the HIV vaccine.
RE_POST
ClinicalTrial site link to VRC-ZKADNA085-00-VP.
LINK
https://clinicaltrials.gov/ct2/show/NCT02840487
That is the numbered drug that GeoVax is working on, imo.
View the 60 Minutes segment from last night.
Stop & start the video until you can get a clear reading of the vial.
The vial # is VRC-ZKADNA085-00-VP.
In addition, the company that GeoVax uses to produce larger quantities of its test drugs is listed as the manufacturer. I will not post that name.
in short, if you know what you are looking at, 60 Minutes demonstrated that the Geovax Zika Virus vaccine works in creating a lasting response.
The big smile on Dr. Anthony Faucci's face and his comments after the sample turn blue leave NO DOUBT that the vaccine works.
This is my opinion based on my DD.
Anyone can do the same DD.
NOTE: THAT IS THE GEOVAX VACCINE PLATFORM WITH A ZIKA VIRUS ADDED.IMO.
AS EXPLAINED BY 60 MINUTES, MANY VIRUS TYPES CAN BE ADDED TO MAKE A SPECIFIC VACCINE FOR THAT VIRUS USING THE EXACT SAME PLATFORM. GOOGLE "DNA, PLASMID".
Landmark day for human AIDS vax & GeoVax.
Today, GeoVax re-affirmed their elite status as one of the few bio/pharma companies, anywhere, that are directly associated with human AIDS vaccine trials.
Just astounding that the GeoVax market cap is $3.3M dollars.
The lab equipment is worth half that number.
The stock price is at an inflection point right on the 200DMA.
IMO, todays news has serious legs and will continue to reverberate in coming sessions.
Many serious investors and casual onlookers alike will move on to the next level of DD in regard to GeoVax now.
At some point GOVX goes InPlay, imo.
Reuters:
http://www.reuters.com/article/idUSASB0AW7P?type=companyNews&feedType=RSS
GOVX @ .07: Historic human vaccinations for AIDS started today.
GeoVax has a market cap of $3.2M. Totally insane.
GOVX one of the great bio/pharma plays right now.
A true milestone event
LINK:
https://www.geovax.com/component/easyblog/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html?Itemid=101
GOVX @. 07: Landmark News. AIDS prevention human vaccinations begin.
GeoVax @ .07 & a tiny 42M float. Market cap is an insane $3.2M
Today, GOVX started giving vaccinations to humans to prevent AIDS.
This vaccination program is totally funded by the Feds.
GeoVax is one of the truly great bio/pharma plays right now.
Here is a link to todays news which is not widely known yet but the stock is starting to move.
Link:
https://www.geovax.com/component/easyblog/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html?Itemid=101
NOTE: GOVX @ .07 is right at the 200DMA. A key tech indicator.
GOVX @. 07: Milestone human vaccinations for AIDS prevention start. Historic.
GeoVax @ .07 & a tiny 42M float. Market cap is an insane $3.2M
Today, GOVX started giving vaccinations to humans to prevent AIDS.
This vaccination program is totally funded by the Feds.
GeoVax is one of the truly great bio/pharma plays right now.
Here is a link to todays news which is not widely known yet but the stock is starting to move.
Link:
https://www.geovax.com/component/easyblog/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html?Itemid=101
NOTE: GOVX @ .07 is right at the 200DMA. A key tech indicator.
GOVX @. 07: Historic human AIDS vaccination news today.
GeoVax @ .07 & a tiny 42M float. Market cap is an insane $3.2M
Today, GOVX started giving vaccinations to humans to prevent AIDS.
This vaccination program is totally funded by the Feds.
GeoVax is one of the truly great bio/pharma plays right now.
Here is a link to todays news which is not widely known yet but the stock is starting to move.
Link:
https://www.geovax.com/component/easyblog/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html?Itemid=101
NOTE: GOVX @ .07 is right at the 200DMA. A key tech indicator.
GOVX @. 07: Historic human AIDS vaccination news today.
GeoVax @ .07 & a tiny 42M float. Market cap is an insane $3.2M
Today, GOVX started giving vaccinations to humans to prevent AIDS.
This vaccination program is totally funded by the Feds.
GeoVax is one of the truly great bio/pharma plays right now.
Here is a link to todays news which is not widely known yet but the stock is starting to move.
Link:
https://www.geovax.com/component/easyblog/entry/2017/01/23/geovax-announces-initiation-of-hiv-human-clinical-trial.html?Itemid=101
NOTE: GOVX @ .07 is right at the 200DMA. A key tech indicator.
CRTN @ $1.40s: InPlay. Only profitable Nas co. trading under $4.00.
Take a look at action.
Tiny float about to lock.
Big move on tap
CRTN @ $1.40s: InPlay. Only profitable Nas co. trading under $4.00.
Take a look at action.
Tiny float about to lock.
Big move on tap
GOVX:..MAJOR NEWS..Human AIDS vaccination program begins.
This is the highly anticipated next step in the GeoVax AIDS prevention vaccine program.
Funded by Feds
Link:
<A HREF="http://www.thelion.com/bin/redir.cgi?tgt=http%3A%2F%2Ffinance.yahoo.com%2Fnews%2Fgeovax-announces-initiation-hiv-human-140000997.html&id=38103&blog=1">http://finance.yahoo.com/news/geovax-announces-initiation-hiv-human-140000997.html</A>
GOVX @ .07: Human AIDS vaccination program begins.
This is the highly anticipated next step in the GeoVax AIDS prevention vaccine program.
Funded by Feds.
Link:
http://finance.yahoo.com/news/geovax-announces-initiation-hiv-human-140000997.html
NOTE: This news release just appeared on stock screener. General release in a few minutes, I believe.
BIOL: FDA news posted here last week. Co. PR out now.
Link:
https://finance.yahoo.com/news/biolase-announces-fda-clearance-worldwide-110000046.html
Link from last week.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=127975786
NOTE: Imo, this news does not have a lot of legs. If you were not in based on last weeks notice, likely not a lot of upside from this pop. Just my opinion.
NOTE 2: CRTN in similar situation. Limited number of investors know two important PRs are coming and are actionable now. When the news IS posted it will pop the stock. I would NOT sell the CRTN pop however unless it is over $5.00
GOVX: Opens week @ 200DMA. Key technical indicator.
GeoVax has been trading nicely over the 50DMA and now is set up to test the 200DMA.
200 DMA link:
http://www.investinganswers.com/financial-dictionary/technical-analysis/200-day-moving-average-1222
CRTN : Nasdaq full compliance. PR Mon.?
Certainly.
Next target is week of 2/6/17 Q4 earnings report.
All signs point to sterling report.
True turnaround play.
CRTN valued over $5.00 when it was in profit. No reason why it should not regain that value.
CRTN @ $1.18: NEWS!..Very strong growth.
http://finance.yahoo.com/news/cartesian-reports-continued-growth-network-130100696.html